Overview

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Status:
Not yet recruiting
Trial end date:
2026-07-31
Target enrollment:
0
Participant gender:
All
Summary
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yale University
Collaborators:
BJC HealthCare
Children's Healthcare of Atlanta
Children's Hospital Colorado
Children's Hospital Medical Center, Cincinnati
Children's Hospital of Philadelphia
Children's of Alabama
Golisano Children's Hospital
Maria Fareri Children's Hospital
Medical College of Wisconsin
Nationwide Children's Hospital
New York Presbyterian Hospital
Penn State University
University of Iowa
Virginia Commonwealth University
Treatments:
Enoxaparin
Criteria
Inclusion criteria

1. >36 weeks corrected gestational to <17 years old

2. <24 hours after insertion of an untunneled CVC

3. CVC inserted in the internal jugular or femoral vein

Exclusion criteria

1. Radiologic diagnosis of CADVT in the site of insertion in prior 6 weeks

2. Currently receiving an antithrombotic agent, e.g., LMWH, UFH, warfarin and aspirin,
but not UFH at dose to maintain patency of a vascular catheter

3. Presence of clinically relevant bleeding, i.e., hemoglobin decreased ≥2 g/dl in 24
hours, required medical or surgical intervention to restore hemostasis, or in the
retroperitoneum, pulmonary, intracranial or central nervous system, in the prior 60
days

4. Surgery in the prior 7 days

5. Major trauma in the prior 7 days

6. Presence of coagulopathy, i.e., INR >2.0, aPTT >50 seconds or platelet count <50 x
10^3/mcL

7. Presence of renal failure, i.e., creatinine clearance <30 mL/min/1.73 m2

8. Known hypersensitivity to heparin or pork products

9. Laboratory confirmed HIT

10. Current pregnancy or lactation

11. Presence of an epidural catheter

12. Limitation of care

13. Previous enrollment in the CRETE Studies